Ketamine Therapy Clinics in Delaware

Clinics in Delaware see patients for a range of conditions that have not improved with conventional care. The most common are treatment-resistant depression, PTSD, OCD, anxiety disorders, and certain chronic pain conditions. A licensed provider at the clinic will determine whether ketamine therapy is appropriate for your specific history and diagnosis.

IV ketamine is delivered through a drip in a clinical setting and is used off-label, meaning it is not FDA-approved for the mental health conditions it is commonly used for. Spravato is an FDA-approved esketamine nasal spray that is administered at the clinic and requires a waiting period afterward for monitoring.

The two also differ in cost structure and insurance coverage. Spravato is more likely to be covered by insurance, while IV infusions are almost always self-pay. Your provider can help you weigh which makes more sense for your situation.

You will be in a clinical setting for the entire appointment, which typically lasts between 45 minutes and a few hours depending on the format. Staff monitor your blood pressure, heart rate, and overall condition throughout. Most people rest in a chair or reclined position, and you will need someone to drive you home afterward.

The main cities with clinics are Wilmington, Newark, Dover, and Smyrna. The northern part of the state has the most options, but Spravato is offered at clinics spread across multiple cities, giving people in central Delaware real choices closer to home.

Very few clinics in Delaware publish their rates online, so it is hard to give a meaningful price range without calling directly. Costs generally depend on which treatment format is used and the length of the initial course of sessions. Ask each clinic for a full written breakdown before committing.

Most ketamine therapy, particularly IV infusions, is not covered by insurance and is paid out of pocket. Spravato is the exception.

Because it is FDA-approved, some insurance plans do cover it, though approval depends on your specific plan, your diagnosis, and whether prior treatments were tried first. Confirm coverage directly with your insurer and the clinic.

No. Every clinic listed here provides treatment in person at a physical location. At-home or telehealth ketamine services are not included in this directory.

Start by confirming which treatment format is offered, since not every clinic provides both IV infusions and Spravato. Then look at who provides the care, what the intake process involves, and whether the clinic supports follow-up beyond the initial sessions. Because published pricing is limited, calling directly to ask for a cost breakdown is a practical first step.

Yes. Ketamine is a Schedule III controlled substance under U.S. federal law and is legal for licensed clinicians to prescribe and administer off-label, including for treatment-resistant depression and other conditions.

Spravato (esketamine), the FDA-approved nasal-spray form, is dispensed only in certified healthcare settings under a federal Risk Evaluation and Mitigation Strategy (REMS) program. That applies in Delaware as it does nationwide.

The standards for who may administer treatment are set by state regulators and by the clinicians themselves; you can look up the current licensing board for your state through the Federation of State Medical Boards directory at fsmb.org. This page is informational and not legal or medical advice. Consult a licensed medical provider before starting treatment.